Insmed announces proposed concurrent public offerings of common stock and convertible senior notes due 2028

Bridgewater, n.j., may 10, 2021 /prnewswire/ — insmed incorporated (nasdaq: insm) announced today that it intends to offer and sell $250 million of its common stock (the "shares") and $500 million aggregate principal amount of its convertible senior notes due 2028 (the "notes") in separate concurrent underwritten public offerings, a portion of which will be used to repurchase insmed's existing outstanding convertible senior notes due 2025.
INSM Ratings Summary
INSM Quant Ranking